Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
RESEARCH TOOLSreports
Black Diamond Therapeutics (BDTX) Ownership - Who Owns Black Diamond Therapeutics?
705 Followers
Black Diamond Therapeutics (BDTX) Ownership Overview
63.79% Insiders
9.62% Mutual Funds
3.83% Other Institutional Investors
22.77% Public Companies and
Individual Investors
The ownership structure of Black Diamond Therapeutics (BDTX) stock is a mix of institutional, retail and individual investors. Approximately 13.45% of the company’s stock is owned by Institutional Investors, 63.79% is owned by Insiders and 22.77% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 19, 2023 | Biotech Growth N V >10% Owner | Bought | $932000 |
| Jul 07, 2023 | Ra Capital Management, Llc Director | Bought | $4679250 |
| Jul 06, 2023 | Ali Behbahani Director | Bought | $5000000 |
| Jul 03, 2023 | Biotech Growth N V >10% Owner | Bought | $5000000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $241148 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,525,754 | Institution | 6.82% | 17,664,028 | |
| 2,317,200 | Institution | 4.48% | 11,609,172 | |
| 1,886,158 | Institution | 3.65% | 9,449,652 | |
| 1,846,239 | Institution | 3.57% | 9,249,657 | |
| 930,447 | Institution | 1.80% | 4,661,539 | |
| 696,969 | Institution | 1.35% | 3,491,815 | |
| 337,624 | Institution | 0.65% | 1,691,496 | |
| 184,800 | Institution | 0.36% | 925,848 | |
| 85,818 | Institution | 0.17% | 429,948 | |
| 70,420 | Institution | 0.14% | 352,804 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,317,200 | Institution | 4.48% | 11,609,172 | |
| 1,886,158 | Institution | 3.65% | 9,449,652 | |
| 337,624 | Institution | 0.65% | 1,691,496 | |
| 184,800 | Institution | 0.36% | 925,848 | |
| 50,030 | Institution | 0.10% | 250,650 | |
| 39,005 | Institution | 0.08% | 195,415 | |
| 37,938 | Institution | 0.07% | 190,069 | |
| 27,640 | Institution | 0.05% | 138,476 | |
| 27,380 | Institution | 0.05% | 137,174 | |
| 27,000 | Institution | 0.05% | 135,270 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,206,831 | Institution | 2.33% | 6,118,633 | |
| 639,408 | Institution | 1.24% | 3,241,799 | |
| 70,420 | Institution | 0.14% | 352,804 | |
| 33,623 | Institution | 0.07% | 168,451 | |
| 1,678 | Institution | <0.01% | 8,424 | |
| 1,054 | Institution | <0.01% | 5,281 | |
| 100 | Institution | <0.01% | 501 | |
| 16 | Institution | <0.01% | 84 |
FAQ
Who Owns Black Diamond Therapeutics (BDTX)?
According to the latest TipRanks data, approximately 3.83% of the company's stock is held by institutional investors, 63.79% is held by insiders, and 22.77% is held by retail investors.
What percentage of Black Diamond Therapeutics (BDTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.83% of Black Diamond Therapeutics (BDTX) stock is held by institutional investors.
What percentage of Black Diamond Therapeutics (BDTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 22.77% of Black Diamond Therapeutics (BDTX) stock is held by retail investors.
Who owns the most shares of Black Diamond Therapeutics (BDTX)?
Peter Kolchinsky owns the most shares of Black Diamond Therapeutics (BDTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.